December 05, 2020
Global pharma major Pfizer, on Thursday, said that it remains committed
to engaging with the Indian government to explore opportunities to make
Pfizer/BioNTech vaccine available in the country. On Wednesday, the UK
became the first country to approve Pfizer/BioNTech against COVID-19.
The Medicines and Healthcare Products Regulatory Agency (MHRA) of the
United Kingdom has granted temporary approval for its emergency use.
"Right now we are in discussions with many governments around the world
and remain committed to engaging with the Government of India and
explore opportunities to make this vaccine available for use in the
country," a Pfizer spokesperson said in a statement.
Pfizer is committed to ensuring everyone has the opportunity to have
access to the vaccine, and is working closely with governments, it
"During this pandemic phase, Pfizer will supply this vaccine only
through government contracts based on agreements with respective
government authorities and following regulatory authorisation or
approval," the statement said.
The United Kingdom's regulator, MHRA, has issued a temporary
authorization for the emergency use of the COVID-19 mRNA